These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 10657748)
1. Comparison of the effects of preserved and unpreserved formulations of timolol on the ocular surface of albino rabbits. Pisella PJ; Fillacier K; Elena PP; Debbasch C; Baudouin C Ophthalmic Res; 2000; 32(1):3-8. PubMed ID: 10657748 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the short-term effects on the human corneal surface of topical timolol maleate with and without benzalkonium chloride. Ishibashi T; Yokoi N; Kinoshita S J Glaucoma; 2003 Dec; 12(6):486-90. PubMed ID: 14646684 [TBL] [Abstract][Full Text] [Related]
3. [Toxicity of preserved and unpreserved beta-blocker eyedrops in an in vitro model of human conjunctival cells]. de Saint Jean M; Debbasch C; Brignole F; Rat P; Warnet JM; Baudouin C J Fr Ophtalmol; 2000 Feb; 23(2):111-21. PubMed ID: 10705112 [TBL] [Abstract][Full Text] [Related]
4. Reduced in vivo ocular surface toxicity with polyquad-preserved travoprost versus benzalkonium-preserved travoprost or latanoprost ophthalmic solutions. Liang H; Brignole-Baudouin F; Riancho L; Baudouin C Ophthalmic Res; 2012; 48(2):89-101. PubMed ID: 22473057 [TBL] [Abstract][Full Text] [Related]
5. Comparison of the in vitro tolerance and in vivo efficacy of traditional timolol maleate eye drops versus new formulations with bioadhesive polymers. Andrés-Guerrero V; Vicario-de-la-Torre M; Molina-Martínez IT; Benítez-del-Castillo JM; García-Feijoo J; Herrero-Vanrell R Invest Ophthalmol Vis Sci; 2011 Jun; 52(6):3548-56. PubMed ID: 21296826 [TBL] [Abstract][Full Text] [Related]
6. Effects of timolol-related ophthalmic solutions on cultured human conjunctival cells. Kawase K; Lin W; Aoyama Y; Yamamoto T; Shimazawa M; Hara H Jpn J Ophthalmol; 2010 Nov; 54(6):615-21. PubMed ID: 21191725 [TBL] [Abstract][Full Text] [Related]
7. [A comparative study of the ocular tolerance of 3 timolol-based preparations: the influence of preservatives on ocular tolerance]. Furrer P; Berger J; Mayer JM; Gurny R J Fr Ophtalmol; 2001 Jan; 24(1):13-9. PubMed ID: 11240466 [TBL] [Abstract][Full Text] [Related]
8. Short-term comparative study of the effects of preserved and unpreserved topical levofloxacin on the human ocular surface. Bai T; Huang J; Wang W Cutan Ocul Toxicol; 2010 Dec; 29(4):247-53. PubMed ID: 20550489 [TBL] [Abstract][Full Text] [Related]
9. Influence of timolol, benzalkonium-preserved timolol, and benzalkonium-preserved brimonidine on oxidative stress biomarkers in the tear film. Sedlak L; Wojnar W; Zych M; Wyględowska-Promieńska D Cutan Ocul Toxicol; 2020 Sep; 39(3):260-268. PubMed ID: 32594785 [TBL] [Abstract][Full Text] [Related]
10. The transcorneal penetration of commercial ophthalmic formulations containing timolol maleate in rabbit eyes. Fukuda M; Sasaki H J Ocul Pharmacol Ther; 2015 Feb; 31(1):57-60. PubMed ID: 25303115 [TBL] [Abstract][Full Text] [Related]
11. Comparative study of in vitro ocular surface cytotoxicity of a fixed combination of 0.5% timolol/1% dorzolamide eyedrop and its components with 0.005% benzalkonium chloride. Ayaki M; Iwasawa A; Niwano Y Biocontrol Sci; 2012; 17(3):115-20. PubMed ID: 23007102 [TBL] [Abstract][Full Text] [Related]
12. Corneal and conjunctival changes caused by commonly used glaucoma medications. Noecker RJ; Herrygers LA; Anwaruddin R Cornea; 2004 Jul; 23(5):490-6. PubMed ID: 15220734 [TBL] [Abstract][Full Text] [Related]
13. Effects of benzalkonium chloride- and polyquad-preserved combination glaucoma medications on cultured human ocular surface cells. Ammar DA; Noecker RJ; Kahook MY Adv Ther; 2011 Jun; 28(6):501-10. PubMed ID: 21603985 [TBL] [Abstract][Full Text] [Related]
14. In vitro comparative toxicology of polyquad-preserved and benzalkonium chloride-preserved travoprost/timolol fixed combination and latanoprost/timolol fixed combination. Brignole-Baudouin F; Riancho L; Liang H; Nakib Z; Baudouin C J Ocul Pharmacol Ther; 2011 Jun; 27(3):273-80. PubMed ID: 21410334 [TBL] [Abstract][Full Text] [Related]
15. Comparison of corneal and conjunctival changes after dosing of travoprost preserved with sofZia, latanoprost with 0.02% benzalkonium chloride, and preservative-free artificial tears. Kahook MY; Noecker RJ Cornea; 2008 Apr; 27(3):339-43. PubMed ID: 18362664 [TBL] [Abstract][Full Text] [Related]
16. Comparison of toxicological profiles of benzalkonium chloride and polyquaternium-1: an experimental study. Labbé A; Pauly A; Liang H; Brignole-Baudouin F; Martin C; Warnet JM; Baudouin C J Ocul Pharmacol Ther; 2006 Aug; 22(4):267-78. PubMed ID: 16910868 [TBL] [Abstract][Full Text] [Related]
17. Very-high-frequency ultrasound corneal imaging as a new tool for early diagnosis of ocular surface toxicity in rabbits treated with a preserved glaucoma drug. Denoyer A; Ossant F; Arbeille B; Fetissof F; Patat F; Pourcelot L; Pisella PJ Ophthalmic Res; 2008 Oct; 40(6):298-308. PubMed ID: 18506111 [TBL] [Abstract][Full Text] [Related]
18. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma. Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826 [TBL] [Abstract][Full Text] [Related]
19. [Effect of preservatives on the conjunctiva: a comparative study of beta-blocker eye drops with and without preservatives in glaucoma patients]. Pisella PJ; Lala E; Parier V; Brignole F; Baudouin C J Fr Ophtalmol; 2003 Sep; 26(7):675-9. PubMed ID: 13130254 [TBL] [Abstract][Full Text] [Related]